Related Experiment Video
Updated: Jul 2, 2025

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
[Change in the prevention of kidney stones]
Cyril Derouet1, Sébastien Kissling1, Beat Roth2
1Service de néphrologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
Kidney stone is one of the most frequent disorders of the urinary tract. Once the stone has passed, the management should be oriented on prevention. If changes in lifestyle and diet should be implemented in a true therapeutic education of the patient, prescription of drugs has been recently challenged by the NOSTONE trial. This randomized controlled trial did not show any benefit of hydrochlorothiazide in the prevention of recurrence of kidney stone event in patients with calcium-containing stone. Therefore, prescription of thiazide in the sole purpose of decreasing kidney stone recurrence should be limited and the risk/benefit of this treatment should be carefully balanced for each case.
Insights
Preventing kidney stones after passing a calcium-containing stone may not benefit from hydrochlorothiazide. Careful risk-benefit assessment is needed for thiazide prescriptions in kidney stone prevention.
Area of Science:
- Nephrology
- Urology
- Pharmacology
Context:
- Kidney stones are common urinary tract disorders.
- Post-passage management focuses on prevention.
- Lifestyle and dietary changes are key components of patient education.
Purpose:
- To evaluate the efficacy of hydrochlorothiazide in preventing kidney stone recurrence.
- To challenge the routine prescription of drugs for kidney stone prevention.
Summary:
- The NOSTONE trial, a randomized controlled trial, investigated hydrochlorothiazide's role in preventing kidney stone recurrence in patients with calcium-containing stones.
- The trial found no significant benefit of hydrochlorothiazide in reducing kidney stone recurrence.
- This suggests thiazide prescription solely for prevention should be limited.
Impact:
- Clinical practice guidelines for kidney stone prevention may need revision.
- Physicians should carefully weigh the risks and benefits of thiazide therapy for individual patients.
- Further research may explore alternative or adjunct therapies for kidney stone prevention.
Related Concept Videos
Antihypertensive Drugs: Potassium-Sparing Diuretics
Kidney Structure
Cancer Prevention
Some...
Internal Anatomy of the Kidney
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
Antihypertensive Drugs: Action of Diuretics
Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...

